Adherence to international guidelines for the treatment of meningitis infections in Lebanon

References

1. ↵
   1. Van de Beek D,
   2. de Gans J,
   3. Spanjaard L,
   4. Weisfelt M,
   5. Reitsma JB,
   6. Vermeulen M

   (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351:1849–1859.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Talan DA,
   2. Zibulewsky J

   (1993) Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med 22:1733–1738.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Centers for Disease Control and Prevention (CDC)

   (2005) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54:893–897.

   OpenUrlPubMed
4. ↵
   1. Lukšić I,
   2. Mulić R,
   3. Falconer R,
   4. Orban M,
   5. Sidhu S,
   6. Rudan I

   (2013) Estimating global and regional morbidity from acute bacterial meningitis in children:assessment of the evidence. Croat Med J 54:510–518.

   OpenUrlCrossRefPubMed
5. ↵
   1. Aronin SI,
   2. Peduzzi P,
   3. Quagliarello VJ

   (1998) Community-acquired bacterial meningitis:risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 129:862–869.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Ministry of Public Health

   Epidemiological Surveillance, Available from https://www.moph.gov.lb/en/Pages/2/193/epidemiological-surveillance. [cited 2019].
7. ↵
   1. Tunkel AR,
   2. Hartman BJ,
   3. Kaplan SL,
   4. Kaufman BA,
   5. Roos KL,
   6. Scheld WM,
   7. et al.

   (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267–1284.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Sabaté E

   (2003) Adherence to long-term therapies:evidence for action (World Health Organization, Geneva, (CH)) Available from: https://www.who.int/chp/knowledge/publications/adherence_report/en/.
9. ↵
   1. Thigpen MC,
   2. Whitney CG,
   3. Messonnier NE,
   4. Zell ER,
   5. Lynfield R,
   6. Hadler JL,
   7. et al.

   (2011) Bacterial meningitis in the United States, 1998-2007. N Engl J Med 364:2016–2025.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Chia D,
    2. Yavari Y,
    3. Kirsanov E,
    4. Aronin SI,
    5. Sadigh M

    (2015) Adherence to standard of care in the diagnosis and treatment of suspected bacterial meningitis. Am J Med Qual 30:539–542.

    OpenUrlCrossRefPubMed
11. ↵
    (2016) Ministry of Public Health in Lebanon (LB), Available from: http://www.moph.gov.lb/.
12. ↵
    1. Jarousha AM,
    2. Afifi AA

    (2014) Epidemiology and risk factors associated with developing bacterial meningitis among children in Gaza strip. Iran J Public Health 43:1176–1183.

    OpenUrl
13. ↵
    1. Sheley J,
    2. Willman D,
    3. Downen J,
    4. Bergman S

    (2016) Investigation of the selection and timing of pharmacological therapy in community-acquired bacterial meningitis. P T 41:437–441.

    OpenUrl
14. ↵
    1. Logan SA,
    2. MacMahon E

    (2008) Viral meningitis. BMJ 336:36–40.

    OpenUrlFREE Full Text
15. ↵
    1. Ciofi degli Atti M,
    2. Esposito S1,
    3. Parola L,
    4. Ravà L,
    5. Gargantini G,
    6. Longhi R,
    7. et al.

    (2014) In-hospital management of children with bacterial meningitis in Italy. Ital J Pediatr 40:87.

    OpenUrl
16. ↵
    1. Strelow VL,
    2. Miranda ÉJ,
    3. Kolbe KR,
    4. Framil JV,
    5. Oliveira AP,
    6. Vidal JE

    (2016) Meningococcal meningitis:clinical and laboratorial characteristics, fatality rate and variables associated with in-hospital mortality. Arq Neuropsiquiatr 74:875–880.

    OpenUrl
17. ↵
    1. Choi C

    (2001) Bacterial meningitis in aging adults. Clin Infect Dis 33:1380–1385.

    OpenUrlCrossRefPubMedWeb of Science